Improved long-term protection against Mycobacterium tuberculosis Beijing/W in mice after intra-dermal inoculation of recombinant BCG expressing latency associated antigens.

Abstract

Bacille Calmette-Guérin (BCG) is the vaccine against tuberculosis (TB), but has varied efficacy in different geographical locations. Recombinant strategies to genetically modify the organism to enhance the quality of the immune response have aimed at improving BCG efficacy. Here we describe such a strategy using rBCGΔureC∷hly expressing defined latency-associated antigens and test this construct for long-term protection against an isolate of the Mycobacterium tuberculosis (Mtb) Beijing/W lineage. Expression of the antigens Rv2659c, Rv3407 and Rv1733c by rBCGΔureC∷hly improved long-term efficacy in both lung and spleen at day 200 post-infection after intradermal vaccination of mice. Our data support expression of Mtb latency associated antigens by rBCG to improve protection against Mtb.

DOI: 10.1016/j.vaccine.2011.07.144
0204060201220132014201520162017
Citations per Year

83 Citations

Semantic Scholar estimates that this publication has 83 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Reece2011ImprovedLP, title={Improved long-term protection against Mycobacterium tuberculosis Beijing/W in mice after intra-dermal inoculation of recombinant BCG expressing latency associated antigens.}, author={Stephen T. Reece and Ali Nasser-Eddine and Jes Dietrich and Maik Stein and Ulrike Zedler and Sandra Schommer-Leitner and Tom H M Ottenhoff and Peter Andersen and Stefan H E Kaufmann}, journal={Vaccine}, year={2011}, volume={29 47}, pages={8740-4} }